1. Recent Funding
2. Investors
3. ARCH Venture Partners

ARCH Venture Partners has backed 4 companies on Recent Funding, 1 in the last 12 months; its most recent deal is LifeMine Therapeutics (2026-08-06).

What ARCH Venture Partners invests in

• Health and bio · 4 · 100%

How ARCH Venture Partners invests

Share is of the 9 rounds on Recent Funding that name ARCH Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with ARCH Venture Partners	Total raised	Latest raise
LLifeMine Therapeutics Health and bio	Aug 6, 2026 Series b+ · $188M	$543M	Aug 6, 2026 Series b+
SSeaport Therapeutics Health and bio	Oct 21, 2024 Series b+ · $225M	$325M	Oct 21, 2024 Series b+
MMirador Therapeutics Health and bio	Mar 21, 2024 Series a · $400M · lead	$650M	Jan 13, 2026 Series b+
PParabilis Medicines Health and bio	Mar 1, 2024 Series b+ · $145M	$801M	Jan 8, 2026 Series b+

Most frequent co-investors

• MMilky Way Investments3 shared rounds · last Aug 6, 2026
• FForesite Capital3 shared rounds · last Oct 21, 2024
• FFidelity Management & Research Company3 shared rounds · last Mar 1, 2024
• GGV3 shared rounds · last Mar 23, 2022
• BBlue Pool Capital3 shared rounds · last Mar 23, 2022
• MMRL Ventures Fund3 shared rounds · last Mar 23, 2022
• RRA Capital Management2 shared rounds · last Aug 6, 2026
• GGSK2 shared rounds · last Aug 6, 2026
• IInvus2 shared rounds · last Oct 21, 2024
• SSofinnova Investments2 shared rounds · last Oct 21, 2024
• TThird Rock Ventures2 shared rounds · last Oct 21, 2024
• PPureTech Health2 shared rounds · last Oct 21, 2024

Portfolio companies are the companies on Recent Funding with a round that lists ARCH Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/arch-venture-partners. All investors.